Listen
What are top 5 catalysts for psychedelic stocks in the second half of 2021? Stay tuned to hear how stocks...
In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual...
Check out atai Life Sciences' earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w What's up psychedelic stocks investors?!? Today marked MindMed's (MNMD /MMED) Second Quarter...
What's up psychedelic stocks investors?!? Today marked atai Life Science's (Nasdaq: atai) first-ever conference call, for Quarter 2, 2021. In...
MindMed's Financial Results & Business Update for Q2 2021 are out! In this episode, we'll discuss MindMed, ( MMED: NEO),...
In today’s episode of the Psychedelic Spotlight podcast, we spotlight Henri Sant-Cassia, Co-Founding Partner of The Conscious Fund, a leading...
Mydecine (OTC: MYCOF, NEO: MYCO) is an aspiring psychedelics medicine company that aims to use psilocybin, the active ingredient in...
In today’s episode of the Psychedelic Spotlight podcast, we feature Laura Dawn- a microdosing mentor, visionary life coach, business consultant,...
As technological change revolutionizes medicine and healthcare, how do we ensure that no-one, particularly members of vulnerable groups, get left...
MindMed's Interim CEO, Robert Barrow, has not made as many public appearances as opposed to MMED's previous CEO, Jr Rahn....